Bio Rad Laboratories Stock Performance
| BIO Stock | USD 264.19 2.13 0.81% |
Bio Rad has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.8, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Rad will likely underperform. Bio Rad Laboratories right now shows a risk of 2.36%. Please confirm Bio Rad Laboratories sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Bio Rad Laboratories will be following its price patterns.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Rad Laboratories are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Bio Rad may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
Actual Historical Performance (%)
One Day Return 0.81 | Five Day Return 4.9 | Year To Date Return (19.00) | Ten Year Return 80.4 | All Time Return 10.3 K |
Last Split Factor 2:1 | Last Split Date 2002-03-08 |
1 | Elysium Therapeutics to Participate in the 2025 BIO International Convention to Discuss Challenge of Fentanyl Rebound and Rescue Medication Designed for Synthet... | 06/05/2025 |
2 | HLA Typing Market Global Forecasts to 2030 Diagnostic Applications Dominate HLA Market with Focus on Infectious Disease Testing | 06/12/2025 |
3 | Digital PCR Market Size, Share Future Opportunities Global Forecast 2025 DataM Intelligence | 06/30/2025 |
4 | Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout | 07/07/2025 |
5 | CRISPR Gene Editing Market Surges USD 4.77in 2025, Vertexs Casgevy, AI-Powered OpenCRISPR-1 and Trisomy 21 Breakthrough Fuels Growth | 07/08/2025 |
6 | Biome Australia Limited Stocks Shoot Up 28 percent But Its PS Still Looks Reasonable | 07/10/2025 |
7 | We Think Bio-Rad Laboratories Can Stay On Top Of Its Debt | 07/14/2025 |
8 | Bio-Rad Laboratories Cut to Hold at Wall Street Zen | 07/16/2025 |
9 | Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025 BIO Stock News | 07/17/2025 |
10 | Saudi Arabia In Vitro Diagnostics Market Report 2025 - Market Set to Surge with Vision 2030 Investments Revenues Forecast to Hit USD 2.4 Billion by 2034 | 07/21/2025 |
11 | Japan In Vitro Diagnostics Market Report and Forecast 2025-2034 | 07/22/2025 |
| Begin Period Cash Flow | 404.4 M | |
| Total Cashflows From Investing Activities | -160.2 M |
Bio Rad Relative Risk vs. Return Landscape
If you would invest 24,017 in Bio Rad Laboratories on April 27, 2025 and sell it today you would earn a total of 2,402 from holding Bio Rad Laboratories or generate 10.0% return on investment over 90 days. Bio Rad Laboratories is generating 0.1814% of daily returns assuming volatility of 2.3569% on return distribution over 90 days investment horizon. In other words, 21% of stocks are less volatile than Bio, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Bio Rad Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Rad's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bio Rad Laboratories, and traders can use it to determine the average amount a Bio Rad's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0769
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.36 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Bio Rad is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Rad by adding it to a well-diversified portfolio.
Bio Rad Fundamentals Growth
Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Rad, and Bio Rad fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.
| Return On Equity | -0.28 | ||||
| Return On Asset | 0.0155 | ||||
| Profit Margin | (0.85) % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 6.71 B | ||||
| Shares Outstanding | 22.14 M | ||||
| Price To Earning | 2.90 X | ||||
| Price To Book | 1.05 X | ||||
| Price To Sales | 2.81 X | ||||
| Revenue | 2.57 B | ||||
| Gross Profit | 1.36 B | ||||
| EBITDA | (2.1 B) | ||||
| Net Income | (1.84 B) | ||||
| Cash And Equivalents | 488.1 M | ||||
| Cash Per Share | 62.03 X | ||||
| Total Debt | 1.37 B | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 5.50 X | ||||
| Book Value Per Share | 241.72 X | ||||
| Cash Flow From Operations | 455.2 M | ||||
| Earnings Per Share | (76.53) X | ||||
| Market Capitalization | 7.13 B | ||||
| Total Asset | 9.36 B | ||||
| Retained Earnings | 7.42 B | ||||
| Working Capital | 2.56 B | ||||
| Current Asset | 466.61 M | ||||
| Current Liabilities | 208.93 M | ||||
About Bio Rad Performance
By examining Bio Rad's fundamental ratios, stakeholders can obtain critical insights into Bio Rad's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Bio Rad is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 206.06 | 148.81 | |
| Return On Tangible Assets | (0.21) | (0.20) | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | (0.20) | (0.19) | |
| Return On Equity | (0.28) | (0.27) |
Things to note about Bio Rad Laboratories performance evaluation
Checking the ongoing alerts about Bio Rad for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Rad Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the last year's revenue of 2.57 B. Reported Net Loss for the year was (1.84 B) with profit before taxes, overhead, and interest of 1.36 B. | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Japan In Vitro Diagnostics Market Report and Forecast 2025-2034 |
- Analyzing Bio Rad's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Rad's stock is overvalued or undervalued compared to its peers.
- Examining Bio Rad's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio Rad's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Rad's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio Rad's stock. These opinions can provide insight into Bio Rad's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Earnings Share (76.53) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.